Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Ventura2020on Dec 08, 2020 8:41pm
174 Views
Post# 32064269

Good Thing Growing/Don’t Forget Europe!

Good Thing Growing/Don’t Forget Europe!

I kinda like this Little Green Pharma. CEO has a much better appearance in Interviews lol. I think a good fit for Aphria/CC Pharma for now. Bringing in quality oil for the European market through CC Pharma. 
As we know the 2400 units of oil were successfully delivered to CC Pharma. Should be on the market now and hopefully selling out.
Heres an little update  

Germany

LGP has now delivered its first commercial
shipment of 2,400 units of LGP GMP-manufactured medicinal cannabis oils to CC Pharma GmbH in Germany. This makes LGP the third global medicinal cannabis manufacturer to deliver full plant extract oils into Germany, the third largest medicinal cannabis market globally and the largest medicinal cannabis market currently available to Australian producers. Due to limited local German production, Germany’s primary source of medicinal cannabis is through imports from overseas suppliers, with the market estimated to grow to €1.5 billion by 2025.

Aphria should be in production by Q2, but will take some time to produce. 

The Company remains well placed to service the German market: in addition to its CC Pharma distributorship.

<< Previous
Bullboard Posts
Next >>